“Ligand-gated Ion Channels”的搜索结果
-
RAD51 inhibitor
RI-2 is a reversible RAD51 inhibitor, with an IC50 of 44.17 μM, and specifically inhibits homologous recombination repair in human cells.
了解更多
-
PTEF/CDK9 inhibitor
(-)-BAY-1251152 is an enanthiomer of BAY-1251152 with rotation (-). BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor.
了解更多
-
CDK9 inhibitor
CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection, with an IC50 of 39 nM for CDK9/CycT1, extracted from reference, compound 87.
了解更多
-
Ca2+ channel agonist/CDK2 inhibitor
Ca2+ channel agonist 1 is an agonist of N-type Ca2+ channel and an inhibitor of Cdk2, with EC50s of 14.23 μM and 3.34 μM, respectively, and is used as a potential treatment for motor nerve terminal dysfunction.
了解更多
-
Aurora/PLK dual 抑制剂
AAPK-25 is a potent and selective Aurora/PLK dual inhibitor with anti-tumor activity, which can cause mitotic delay and arrest cells in a prometaphase, reflecting by the biomarker histone H3Ser10 phosphorylation and followed by a surge in apoptosis.
了解更多
-
ATP-competitive STK19 inhibitor
ZT-12-037-01 is a potent, selective, ATP-competitive STK19 inhibitor. ZT-12-037-01 effectively blocks oncogenic NRAS-driven melanocyte malignant transformation and melanoma growth in vitro and in vivo.
了解更多
-
covalent CDK7 inhibitor
bio-THZ1 is a biotinylated version of THZ1 and binds irreversibly to CDK7. THZ1 is a selective and potent covalent CDK7 inhibitor with an IC50 of 3.2 nM.
了解更多
-
LIMK inhibitor
R-10015, a broad-spectrum antiviral compound for HIV infection, acts as a potent and selective inhibitor of LIM domain kinase (LIMK) and binds to the ATP-binding pocket, with an IC50 of 38 nM for human LIMK1.
了解更多
-
KRAS-G12C inhibitor
MRTX1257 is a potent, selective, covalent and irreversible inhibitor of KRAS G12C, MRTX1257 inhibited KRAS dependent ERKphosphorylation in the H358cell assay with an IC50= 900 pM.
了解更多
-
CHK1 inhibitor
CCT245737 is a potent, selective and orally active checkpoint kinase 1 (CHK1) inhibitor. CCT245737 showed CHK1 IC50 = 1.3 nM, CHK2 IC50 = 2440 nM, G2 check point abrogation IC50 = 30 nM. Mouse F (oral)=100%.
了解更多
-
ROCK inhibitor
Ripasudil (K-115) is potent ROCK inhibitor with IC50 of 51 nM and 19 nM for ROCK1 and ROCK2, respectively, used for the treatment of glaucoma and ocular hypertension.
了解更多
-
CDK4/6 抑制剂
PD 0332991 Isethionate是CDK4/6的高选择性抑制剂,IC50分别为11 nM/16 nM。
了解更多
-
Rac GTPase 抑制剂
NSC 23766是Rac特异性GEF TrioN和Tiam 1(IC50 = 50 uM)引起的Rac1激活的细胞可渗透性可逆抑制剂。
了解更多
-
Rac GTPase Inhibitor
EHop-016 is a potent and specific inhibitor of Rac1 and Rac3 GTPase activity that inhibits Vav2 interaction with Rac, Rac-activated PAK1, lamellipodia formation, and cell migration.
了解更多
-
Ras-Raf interaction 抑制剂
Kobe0065抑制锚定依赖性和非依赖性生长,阻断MEK / ERK活性并诱导H-rasG12V转化的NIH3T3细胞凋亡。
了解更多
-
Rac1 activation 抑制剂
SC 23766是Rac1-GEF相互作用的选择性抑制剂。通过Rac特异性鸟嘌呤核苷酸交换因子(GEF)TrioN和Tiam1(IC50为50 μM)阻止Rac1激活,而不影响Cdc42或RhoA激活。
了解更多
-
osteoclastic bone resorption 抑制剂
Zoledronic acid, 破骨细胞抑制剂,通过抑制甲羟戊酸途径诱导破骨细胞凋亡。
了解更多